FDA approves Neuroreader software to help spot brain changes from Alzheimer’s, concussions

Evan Godt | | Health Imaging | Enterprise Imaging

Danish medical device company Brainreader has announced FDA approval for its Neuroreader MR software designed to quickly detect changes in a patient’s brain volume brought on by neurodegenerative diseases or traumatic brain injuries.

The process works by uploading MR images to Neuroreader, which compares them against an FDA-approved database of healthy brain scans. In a matter of minutes, the software can measure 45 different brain structures and report back on changes as small as hundredths of a millimeter, according to a company press release.

Radiologists could use the software to accurately detect abnormalities resulting from Alzheimer’s disease, depression, concussion or a number of other conditions.

Neuroreader is a software-as-a-service product sold either through a subscription or pay-per-use.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Related Content

Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Rads are more accurate when they have access to patients' self-reported symptoms
AI-based software improves follow-up imaging adherence by 74%

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.